At the time of writing, Cognition Therapeutics Inc [CGTX] stock is trading at $0.48, down -6.02%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CGTX shares have gain 12.76% over the last week, with a monthly amount drifted -11.00%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Cognition Therapeutics Inc [NASDAQ: CGTX] stock has seen the most recent analyst activity on July 30, 2024, when Cantor Fitzgerald downgraded its rating to a Neutral. Previously, Oppenheimer started tracking the stock with Outperform rating on November 03, 2021, and set its price target to $22. On November 03, 2021, B. Riley Securities initiated with a Buy rating and assigned a price target of $27 on the stock.
For the past year, the stock price of Cognition Therapeutics Inc fluctuated between $0.34 and $2.95. Cognition Therapeutics Inc [NASDAQ: CGTX] shares were valued at $0.48 at the most recent close of the market.
Analyzing the CGTX fundamentals
Gross Profit Margin for this corporation currently stands at 0.49% with Operating Profit Margin at -157.08%, Pretax Profit Margin comes in at -92.12%, and Net Profit Margin reading is -92.12%. To continue investigating profitability, this company’s Return on Assets is posted at -1.24, Equity is -1.51 and Total Capital is -3.93. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4540 points at the first support level, and at 0.4299 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5081, and for the 2nd resistance point, it is at 0.5381.
Ratios To Look Out For
It is important to note that Cognition Therapeutics Inc [NASDAQ:CGTX] has a current ratio of 2.11. Further, the Quick Ratio stands at 2.11, while the Cash Ratio is 1.73.
Transactions by insiders
Recent insider trading involved Ricciardi Lisa, CEO & President, that happened on Mar 14 ’24 when 5700.0 shares were purchased.
